Male Androgenetic Alopecia

    March 2014 in “ Turkderm
    Zekayi Kutlubay, Süleyman Bağlam, Burhan Engin, Server Serdaroğlu
    Image of study
    TLDR Hair loss in men can be slowed or reversed with treatments like minoxidil and finasteride, but it resumes if treatment stops. It may also indicate early heart disease and obesity.
    The 2014 study "Male androgenetic alopecia" discussed Androgenetic Alopecia (AGA), a common form of hair loss linked to age, genetic factors, and androgens. The disease was observed in the temporal and vertex areas postpuberty, with a decrease in the anagen/telogen ratio. Treatments included topical minoxidil, oral finasteride, and surgical methods. The study found that 15% of male participants experienced new hair growth with minoxidil, 50% had delayed hair loss, and 35% continued to lose hair. A 5% minoxidil solution was more effective than a 2% solution. However, hair loss resumed once treatment stopped. Daily use of 1 mg finasterid resulted in hair increase in 48% of participants by the end of the first year and 66% by the end of the second year. The study also noted that AGA could be an indicator of early-onset coronary diseases, hyperinsulinemia, insulin resistance, and obesity. Future treatments under research included second-generation steroidal 5-alpha inhibitors. The number of participants was not specified.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Dht kills hair, but no one says why?

      in Finasteride/Dutasteride  40 upvotes 1 month ago
      DHT affects hair follicles, contributing to hair loss, but the exact mechanism is unclear. Treatments like finasteride and minoxidil are used to manage hair loss, though they may have side effects and varying effectiveness.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 2 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community Hair greed made me switch to Dut too early

      in Chat  42 upvotes 7 months ago
      The user switched from finasteride to dutasteride for hair loss but faced increased shedding and anxiety, regretting not staying with finasteride longer. Other users shared mixed experiences, advising patience with dutasteride, as it may take up to a year to show results.

    Similar Research

    5 / 1000+ results